OBJECTIVES We used vector flow mapping (VFM) to detect differences in left ventricular blood flow field parameters in different age groups.
RESULTS
In the diastolic phase, the maximum vortex area in the 50-59-year-old group (490.24 AE 117.94 mm 2 ), compared with that of the other three groups, was significantly increased (P < 0.05). There was a significant difference between the 20-29-year-old group and the 40-49-year-old group (321.46 AE 88.60 mm 2 vs 400.11 AE 100.64 mm 2 , P < 0.05). There was no significant difference between the 20-29year-old group and the 30-39-year-old group, or between the 30-39year-old group and the 40-49-year-old group (P > 0.05). In the diastolic phase, the maximum vortex intensity in the 20-29-year-old group (29.55 AE 5.02 m 2 /s) compared with that of the other three groups was significantly increased (P < 0.05). Between the 30-39year-old group and the 50-59-year-old group, there was a significant difference (22.17 AE 3.78 m 2 /s vs 17.26 AE 6.13 m 2 /s, P< 0.05). There was no significant difference between the 30-39-year-old group and the 40-49-year-old group or between the 40-49-year-old group and the 50-59-year-old group (P > 0.05). In the diastolic phase, the maximum vortex number significantly differed in all four groups compared with one another (P < 0.05). The systolic phase maximum vortex area, maximum vortex intensity, and maximum vortex number showed no significant differences (P > 0.05) among the groups.
CONCLUSIONS Some parameters of blood flow field may reflect changes of left ventricular function with age in healthy people.
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The Application and Prognostic Evaluation of STEMI Clinical Pathway in the Treatment of EPCI Patients RESULTS The average D2B time of the group receiving clinical pathway was obviously reduced (P < 0.05) compared to the group not receiving clinical pathway, and the rate of D2B time reaching the standard of the former group is prominently improved (P < 0.05). Of the group receiving clinical pathway, the peak value of CK-MB during hospitalization and the incidence rate of intraoperative ventricular fibrillation decreased obviously (P < 0.05), the average days of hospitalization shorten obviously (P < 0.05), the TIMI Flow Grading after myocardial infarction intervention and the rate of kinetocardiogram LVEF over 50% within one week after surgery enhanced significantly (P < 0.05), and the rate of ECG ST-segment falling back by over 50% within 2 hours after surgery and the rate of normal kinetocardiogram LVDD didn't undergo obvious change compared to the other group. Between the two groups, such indicators as the quality of life (EQ-5D and EQ-VAS) in the first year after operation and the rate of regular out-patient review and routine medicine-taking in the first year after operation in the group receiving clinical pathway were significantly improved (P < 0.05). As for the incidence rate of MACE within a year after operation, there was no notable difference between the two groups (P < 0.05).
CONCLUSIONS The average D2B time of the group receiving clinical pathway was significantly reduced. The peak value of CK-MB during hospitalization and the incidence rate of intraoperative ventricular fibrillation decreased prominently. The average days of hospitalization were significantly shortened. The post-surgery the TIMI Flow Grading after myocardial infarction intervention and the rate of kinetocardiogram LVEF over 50% in the first week after operation both increased significantly. There was no significant change in both the rate of ECG ST-segment falling back by over 50% within 2 hours after surgery and the rate of normal kinetocardiogram LVDD. The quality of life and medication compliance within a year after surgery was enhanced significantly, while the change of the incidence rate of MACE within a year after surgery wasn't notable.
